Clinical Trial Update: High Or Low Dose pOstpartUm Oxytocin at the Time of Cesarean Birth [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating high versus low dose oxytocin given at cesarean birth to address postpartum hemorrhage has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: University of Chicago | Conditions: Postpartum Hemorrhage, Pregnancy Complications | Phase 2 | Status: WITHDRAWN